Back to DE D. E. Shaw & Co., Inc.

KNSAKNSA
9 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in KINIKSA PHARMACEUTICALS INTL

D. E. Shaw & Co., Inc. holds 569,756 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $36.4M as of 2026-Q2. The position was decreased (-40.6% shares). KNSA represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$36.4M

Current Shares

569,756

Total Value Change

+$33.3M

Total Shares Change

+400,108

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
569,756
-40.6%
$36.4M0.0%$63.95
0
2026-Q1
Decreased
959,257
-22.7%
$46.2M0.0%$45.37
0
2025-Q4
Increased
1.2M
+9.5%
$51.2M0.0%$40.99
32
2025-Q3
Increased
1.1M
+43.3%
$44M0.0%$38.77
39
2025-Q2
Increased
791,305
+99.0%
$21.9M0.0%$28.04
46
2025-Q1
Increased
397,745
+24.3%
$8.8M0.0%$23.09
34
2024-Q4
Decreased
320,007
-0.3%
$6.3M0.0%$19.60
0
2024-Q3
Increased
320,997
+89.2%
$8M0.0%$25.00
43
2024-Q2
New
169,648
-
$3.2M0.0%$18.67
37

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used